Patent US5336642A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5336642A Expired / Lapsed US ⏱️ 0.0 years remaining

Canasite-apatite glass-ceramics

Assignee: Corning Inc
•
Filing: 1993-09-01
•
Granted: 1994-08-09
•
Expires: 2013-09-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A glass-ceramic biomaterial having high strength and toughness, a family of glasses from which the glass-ceramic biomaterial can be produced, and a method of production. The material has a primary crystal phase of F-canasite and a secondary crystal phase of F-apatite. The glass family is SiO 2 --CaO--Na 2 O--K 2 O--P 2 O 5 --F. The method may be a single stage heat treatment, or a two stage involving an initial nucleation and a subsequent crystallization.

Inventors

  • 👤 Christine C. Wolcott

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:00
CPC Classifications
C; C03; C03C; C03C10/00; C03C10/16

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 66 words
A glass-ceramic biomaterial having a bending strength greater than 25,000 psi (172 MPa), a fracture toughness greater than 2.3 Kpsi×in 1/2 (2.5 MPa m 1/2 ), a primary crystal phase of F-canasite, a secondary crystal phase of F-apatite, a crystal phase structure including interlocking blades of F-canasite with at least a portion of the F-apatite crystals within the interlocking F-canasite blades, and a residual glassy phase.
Claim 2
Dependent Claim 66 words
A glass-ceramic biomaterial having a bending strength greater than 25,000 psi (172 MPa), a fracture toughness greater than 2.3 Kpsi×in 1/2 (2.5 MPa m 1/2 ), a primary crystal phase of F-canasite, a secondary crystal phase of F-apatite, a crystal phase structure including interlocking blades of F-canasite with at least a portion of the F-apatite crystals within the interlocking F-canasite blades, and a residual glassy phase.
Claim 3
Dependent Claim 73 words
An SiO 2 --CaO--Na 2 O--K 2 O--P 2 O 5 --F glass capable of being thermally converted to a glass-ceramic having F-canasite as a primary crystal phase and F-apatite as a secondary crystal phase and having a composition, as calculated in weight % on an oxide basis, consisting essentially of 42-70% SiO 2 , 20-30% CaO, 6-12% Na 2 O, 3-10% K 2 O, 2-13% P 2 O 5 , and 3-11%.
Claim 4
Dependent Claim 73 words
An SiO 2 --CaO--Na 2 O--K 2 O--P 2 O 5 --F glass capable of being thermally converted to a glass-ceramic having F-canasite as a primary crystal phase and F-apatite as a secondary crystal phase and having a composition, as calculated in weight % on an oxide basis, consisting essentially of 42-70% SiO 2 , 20-30% CaO, 6-12% Na 2 O, 3-10% K 2 O, 2-13% P 2 O 5 , and 3-11%.
Claim 5
Dependent Claim 29 words
A glass in accordance with claim 2 wherein the glass, as melted, is a clear glass containing no more than about 8 weight % P 2 O 5 .
Claim 6
Dependent Claim 29 words
A glass in accordance with claim 2 wherein the glass, as melted, is an opal glass containing no more than about 8 weight % P 2 O 5 .
Claim 7
Dependent Claim 24 words
A glass in accordance with claim 2 wherein the glass, as melted, contains F-apatite crystals and 8-13 weight % P 2 O 5 .
Claim 8
Dependent Claim 24 words
A glass in accordance with claim 2 wherein the glass is self nucleated by CaF 2 , P 2 O 5 , or both.
Claim 9
Independent Claim 105 words
A method of producing a glass-ceramic biomaterial having a primary crystal phase of F-canasite, and a secondary crystal phase of F-apatite, which comprises melting a glass having a composition, as calculated in weight % on an oxide basis, consisting, essentially of 42-70% SiO 2 , 20-30% CaO, 6-12% Na 2 O, 3-10% K 2 O, 2-13% P 2 O 5 , and 3-11% F, cooling the glass below its transformation range and subjecting the glass to a treat treatment at a temperature higher than the glass transformation temperature range, but, not over 950° C., for a time sufficient to produce F-canasite and F-apatite crystal phases.
Claim 10
Independent Claim 105 words
A method of producing a glass-ceramic biomaterial having a primary crystal phase of F-canasite, and a secondary crystal phase of F-apatite, which comprises melting a glass having a composition, as calculated in weight % on an oxide basis, consisting, essentially of 42-70% SiO 2 , 20-30% CaO, 6-12% Na 2 O, 3-10% K 2 O, 2-13% P 2 O 5 , and 3-11% F, cooling the glass below its transformation range and subjecting the glass to a treat treatment at a temperature higher than the glass transformation temperature range, but, not over 950° C., for a time sufficient to produce F-canasite and F-apatite crystal phases.
Claim 11
Dependent Claim 31 words
A method in accordance with claim 7 wherein the heat treatment is in the temperature range of 685°-950° C. for a period of time ranging from four hours to one-half hour.
Claim 12
Dependent Claim 23 words
A method in accordance with claim 9 wherein the heat treatment is at a temperature of about 850° C. for about one hour.
Claim 13
Dependent Claim 25 words
A method in accordance with claim 7 wherein the heat treatment comprises an initial nucleation stage followed by a crystallization stage at a higher temperature.
Claim 14
Dependent Claim 35 words
A method in accordance with claim 10 wherein the initial nucleation stage is at a temperature in the range of 585°-635° C. and the crystallization is at a temperature in the range of 750°-950° C.

References Cited (Backward Citations)

US3981736A Cited
US4386162A Cited
US4397670A Cited
US4536481A Cited
US4775646A Cited
US4643982A Cited
US4652534A Cited
US5536480A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-08-08 1998-02-07 1998-08-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-08-08 2002-02-07 2002-08-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-08-08 2006-02-07 2006-08-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag